Dr. Heinz-Josef Lenz

1. Dr. Heinz-Joseph Lenz. Colorectal cancer precision medicine expert. Biography. 0

Dr. Heinz-Josef Lenz, MD, explains the latest advances in molecular biomarkers and targeted therapies. He details how genetic profiling of tumors is revolutionizing treatment selection...

2. TAS-102 (Lonsurf) in advanced colon cancer. 5-Fluorouracil is still effective chemotherapy in colorectal cancer. 2

Dr. Heinz-Josef Lenz, MD, explains how TAS-102 (Lonsurf) offers a new treatment option for advanced colon cancer. He details the enduring importance of 5-Fluorouracil (5-FU)...

3. Colon cancer tumor markers. Precision medicine diagnosis. 3

Dr. Heinz-Josef Lenz, MD, explains how molecular tumor marker testing is essential for precision medicine in colon cancer. He details the use of KRAS, NRAS,...

4. Cure of stage 4 colon cancer is possible. Treatment of metastatic colorectal cancer. 1

Dr. Heinz-Josef Lenz, MD, explains how a molecular revolution has transformed treatment, making cure a realistic goal for stage 4 colon cancer patients, especially those...

5. Immunotherapy of colon cancer. What is “molecular escape” of the tumor? 4

Dr. Heinz-Josef Lenz, MD, explains how molecular tumor marker testing is critical for treatment decisions. He details the concept of molecular escape, where colon cancer...

6. Liquid biopsy of colon cancer. How to monitor cancer treatment continuously. 5

Dr. Heinz-Josef Lenz, MD, explains how liquid biopsy transforms metastatic colon cancer treatment monitoring. This non-invasive blood test analyzes circulating tumor DNA and RNA to...

7. Colon cancer precision treatment. Genetics of tumor and genetics of patient are inseparable. 6

Dr. Heinz-Josef Lenz, MD, explains how genetic profiling of both the tumor and the patient is inseparable for optimal treatment and prevention. He details the...

8. Stem cells in colon cancer treatment. PRI-724 chemotherapy. 7

Dr. Heinz-Josef Lenz, MD, explains how cancer stem cells cause treatment failure in metastatic colon cancer. He details a novel WNT pathway inhibitor, PRI-724, which...

9. New targeted chemotherapy of colon cancer. TAS-102, Stivarga, Cyramza. 8

Dr. Heinz-Josef Lenz, MD, explains how new targeted chemotherapy medications and molecular profiling are transforming advanced colon cancer treatment. He details the use of EGFR...

10. Treatment of colon cancer by EGFR inhibitors. Cetuximab (Erbitux). Panitumumab (Vectibix). 9

Dr. Heinz-Josef Lenz, MD, explains how EGFR inhibitors cetuximab and panitumumab significantly improve treatment outcomes for metastatic colon cancer patients with wild-type KRAS and NRAS...

11. Paradigm shift in strategy of metastatic colon cancer treatment. 10

Dr. Heinz-Josef Lenz, MD, explains a paradigm shift in metastatic colon cancer treatment strategy. He details how cure is now a realistic goal for some...

12. Future in treatment of colorectal cancer. Precision medicine. 11

Dr. Heinz-Josef Lenz, MD, explains how precision medicine will transform colon cancer treatment and lead to a cure. He details the future of full molecular...

Medical Practice